Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observatoire Prospectif, Longitudinal Dans la Prise en Charge Thérapeutique de La Rectocolite Hémorragique légère à Modérée

NCT01387698 is registered in ClinicalTrials.gov with Ferring Pharmaceuticals as lead sponsor.

NCT NCT01387698
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01387698 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observatoire Prospectif, Longitudinal Dans la Prise en Charge Thérapeutique de La Rectocolite Hémorragique légère à Modérée
Lead sponsor
Ferring Pharmaceuticals
Phase
Observational
Overall status
Completed
Start date
June 30, 2011
Completion date
October 31, 2015
Enrollment
812 (actual)
Sites
158

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis